About Us

Introduction Vision Mission Value Message from Superintendent

Specialties

Anesthesiology Dentistry Dermatology Family Medicine Internal Medicine Medical Imaging Neurology Obstetrics & Gynecology Ophthalmology Orthopedics Surgery Otolaryngology Pediatrics Physical Medicine and Rehabilitation Psychiatry Surgery Urology

Patient & Visitor

Request an Appointment International Outpatient Services Health checkup Medical Records Application Maps & Direction Clinic Hours Admission Information Visiting Hours Emergency Services Charge and Payment

Education & Research

Education & Training Clinical Research

Education & Research

Education & Training
Clinical Research

Department of Education and Medical Research

Division of Medical Research
Introduction:
As a university medical center, research is one of the major core missions as it affects the medical technology and competitiveness. The essence of medical research is innovation, which leads the hospital to become a better and greater institution.

Centre for Clinical Trials
Centre for Medical Research

Centre for Clinical Trials:
In recent years, biotechnology has always been the first priority for the nation’s health care industries; however, the most critical step in new drug developments, i.e., the human clinical trials, has faced the bottleneck for years because of its legal complexity and high costs.
In order to overcome such .bottlenecks, National Taiwan University Hospital Hsinchu Branch established the Center for Clinical Trial in 2013.
The Center has established a clinical research environment and standard operating system to facilitate new drug clinical trial researches by working with leading international pharmaceutical companies on various diseases. Our collaborations significantly speed up new drug clinical research, and subsequently benefits patients around the world.

Centre for Medical Research

Centre for Medical Research coordinates and allocate research budgets, also oversees research progress and quality. It constantly looks for and promote industrial cooperation and external funding.

Samples of researches underway are:

Sponsored

IRB No.

Principal Investigator

Star Date

End Date

Study Name

EPS Biotechnology Corp.

103-006-F

Pao Ling Chang

2014/4/17

2014/9/30

Clinical Glucose Accuracy Evaluation for New Born Baby

Industrial Technology Research Institute

103-018-F

Jui Sheng Sun

2014/11/28

2018/12/31

Developing master cell bank of bone marrow mesenchymal stem cells

TaiGen biotechology Inc.

103-021-F

Chih Cheng Wu

2015/1/1

2015/12/31

A Multi-center, Randomized, Double-Blind, Double-Dummy, parallel, Controlled, Phase III Clinical Trial Evaluating the Efficacy and Safety of Nemonoxacin Malate Sodium Chloride Injection versus Levofloxacin Sodium Chloride Injection in the Treatment of Adult Community-Acquired Pneumonia.

Maisense Inc.

103-034-F

Chih Cheng Wu

2014/12/15

2015/8/31

Accuracy verification for the non-invasive portable cuff-less blood pressure monitor

Thrombosis Research Institute

103-037-E

Chih Cheng Wu

2014/12/29

2018/12/31

Global Anticoagulant Registry in the FIELD observing treatment and outcomes in patients with treated acute Venous Thromboembolic Events

Technology Research Institute

Nil

Jui Sheng Sun

2015/1/1

2015/12/31

Infected Animal model for Artificial joint replacement

Technology Research Institute

Nil

Jui Sheng Sun

2015/1/1

2015/12/31

Evaluations of the bone-tendon interface by using newly-developed titanium interference screw in a rabbit animal model

Technology Research Institute

Nil

Chih Wei Chen

2015/1/1

2015/12/31

3D endoscope with HDR image processing technology and establishment of minimally invasive surgical instruments system of large animal clinical validation model

Technology Research Institute

Nil

Wen Shiang Chen

2015/6/1

2015/12/31

Two-phase hydrogel for treatment of degenerative joint and tendon tear

Astrazeneca

103-070-F

Sheng-Kai Liang

2015/4/1

2017/12/31

A randomized, double-blind, double dummy, placebo-controlled, parallel group, multicentre, phase III study to evaluate the Efficacy and safety of 3 doses of Benralizumab (MEDI-536) in patients with severe to very severe Chronic Obstructive Pulmonary Disease(COPD) with a history of COPD exacerbations (TERRANOVA)

Astrazeneca

104-005-E

Jen-Chung Ko

2015/3/3

2018/3/31

A Phase III, open Label, Randomized Study of AZD9291 versus Platinum-Based Doublet Chemotherapy for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed with Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and whose Tumors harbour a T790M mutation within the Epidermal Growth Factor Receptor Gene(AURA3)

Astrazeneca

104-020-F

Chih Cheng Wu

2015/6/4

2017/3/31

A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial infarction or Stroke in Patients with Type 2 Diabetes Mellitus [THEMIS-Effect of Ticagrelor on Health Outcomes in diabetes Mellitus patients Intervention Study}

Astrazeneca

104-027-F

Chih Cheng Wu

2015/7/28

2017/6/30

A multicenter, singer arm, open label, Phase IV study to evaluate safety of Ticagrelor in Taiwanese patients with acute coronary syndrome